Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: Need for safer conditioning and reduced late effects-Reference-Cited by-同舟云学术

Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: Need for safer conditioning and reduced late effects

Published:2013-05 Issue:5 Volume:131 Page:1306-1311
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Horn Biljana,Cowan Morton J.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference22 articles.

1. Bone marrow transplant for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans;O’Marcaigh;Bone Marrow Transplant,2001

2. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency;Neven;Blood,2009

3. Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis;Railey;J Pediatr,2009

4. Megadose CD34+ cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haploidentical nonmyeloablative transplantation;Dvorak;Biol Blood Marrow Transplant,2008

5. Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies;Titman;Blood,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Immunodeficiency Diseases;Basics of Hematopoietic Stem Cell Transplant;2023

2. Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood;Journal of Clinical Immunology;2022-05-17

3. Updates on Severe Combined Immunodeficiency;Common Pediatric Diseases: an Updated Review;2022-04-13

4. Combining Mobilizing Agents with Busulfan to Reduce Chemotherapy-Based Conditioning for Hematopoietic Stem Cell Transplantation;Cells;2021-04-30

5. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1;New England Journal of Medicine;2019-04-18